Rosemary J Boyton - Univ London Imperial, Hammersmith Hosp

基本信息

浏览量：14

职业迁徙

个人简介

Rosemary J Boyton currently works at the Department of Infectious Disease, Faculty of Medicine, Imperial College London. Rosemary does research in Immunology, Respiratory Medicine and Infectious Diseases.

研究兴趣

论文共 158 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Evidence for Immune Activation in Pathogenesis of the HLA Class II Associated Disease, Podoconiosis

Mikias Negash,Menberework Chanyalew,Tigist Girma,Fekadu Alemu,Diana Alcantara, Ben Towler,Gail Davey,Rosemary J. Boyton,Daniel M. Altmann,Rawleigh Howe,Melanie J. Newport

The Journal of Immunologyno. 1_Supplement (2024): 0592_4589-0592_4589

引用0浏览0WOSNATURE引用

Arming up against Omicron subvariants

Daniel M. Altmann,Rosemary J. Boyton

CELL HOST & MICROBEno. 2 (2024): 147-148

引用0浏览0WOS引用

COVID-19 Vaccine Boosted Immunity Against Omicron in Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

Dragana Milojkovic,Catherine J. Reynolds,Diana Munoz Sandoval,Franziska P. Pieper,Siyi Liu,Corinna Pade,Joseph M. Gibbons,Aine McKnight,Sandra Loaiza,Renuka Palanicawander,Andrew J. Innes,Simone Claudiani,Jane F. Apperley,Daniel M. Altmann,Rosemary J. Boyton

LEUKEMIA（2023）

引用0浏览0WOS引用

The Immunology of Long COVID

Daniel M. Altmann,Emily M. Whettlock,Siyi Liu,Deepa J. Arachchillage,Rosemary J. Boyton

Nature Reviews Immunologypp.1-17, (2023)

引用13浏览0WOSNATURE引用

OP24 Neutralising Antibody Potency Against SARS-CoV-2 Wild-Type and Omicron BA.1 and BA.4/5 Variants in Infliximab and Vedolizumab Treated Patients with Inflammatory Bowel Disease after Three Doses of COVID-19 Vaccine: a Prospective Multicentre Cohort Study

Journal of Crohn's and colitisno. Supplement_1 (2023): i32-i34

引用1浏览0引用

Neutralising Antibody Responses Against SARS-CoV-2 Omicron BA.4/5 and Wild-Type Virus in Patients with Inflammatory Bowel Disease Following Three Doses of COVID-19 Vaccine (VIP): a Prospective, Multicentre, Cohort Study

EClinicalMedicine (2023): 102249-102249

引用0浏览0WOS引用

Persistent Symptoms after COVID-19 Are Not Associated with Differential SARS-CoV-2 Antibody or T Cell Immunity

Daniel M. Altmann,Catherine J. Reynolds,George Joy,Ashley D. Otter,Joseph M. Gibbons,Corinna Pade,Leo Swadling,Mala K. Maini,Tim Brooks,Amanda Semper,Áine McKnight,Mahdad Noursadeghi,Charlotte Manisty,Thomas A. Treibel,James C. Moon,Rosemary J. Boyton

Nature communicationsno. 1 (2023): 5139-5139

引用2浏览0WOSNATURE引用

Redirected Vaccine Imprinting by Co-Administration of COVID-19 and Influenza Vaccines

Rosemary J. Boyton,Daniel M. Altmann

The Lancet regional health Europe (2023): 100644-100644

引用1浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn